Correlation Between Sinphar Pharmaceutical and GenMont Biotech

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and GenMont Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and GenMont Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and GenMont Biotech, you can compare the effects of market volatilities on Sinphar Pharmaceutical and GenMont Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of GenMont Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and GenMont Biotech.

Diversification Opportunities for Sinphar Pharmaceutical and GenMont Biotech

0.74

Correlation Coefficient

Sinphar Pharmaceutical  GenMont Biotech

Poor diversification

The 3 months correlation between Sinphar and GenMont is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and GenMont Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GenMont Biotech and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with GenMont Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GenMont Biotech has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and GenMont Biotech go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and GenMont Biotech

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.8 times more return on investment than GenMont Biotech. However, Sinphar Pharmaceutical Co is 1.25 times less risky than GenMont Biotech. It trades about -0.18 of its potential returns per unit of risk. GenMont Biotech is currently generating about -0.24 per unit of risk. If you would invest  3,344  in Sinphar Pharmaceutical Co on September 3, 2024 and sell it today you would lose (259.00) from holding Sinphar Pharmaceutical Co or give up 7.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  GenMont Biotech

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

GenMont Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GenMont Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Sinphar Pharmaceutical and GenMont Biotech

The main advantage of trading using opposite Sinphar Pharmaceutical and GenMont Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, GenMont Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GenMont Biotech will offset losses from the drop in GenMont Biotech's long position.

The idea behind Sinphar Pharmaceutical Co and GenMont Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.